Viewing Study NCT00952692


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2025-12-26 @ 7:16 PM
Study NCT ID: NCT00952692
Status: COMPLETED
Last Update Posted: 2021-12-20
First Post: 2009-08-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer
Sponsor: Michael Morse, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None HER2 View
None Lapatinib View
None dHER2 ASCI View
None overexpressing HER2 View
None refractory to trastuzumab View